ROCKET PHARMACEUTICALS, INC. (RCKT) Net Income (Loss) Attributable to Parent USD 2014 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Rocket Pharmaceuticals, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2014 to 2024.
  • Rocket Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the quarter ending March 31, 2024 was -$62.1 M, a 6.38% decline year-over-year.
  • Rocket Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending March 31, 2024 was -$249 M, a 5.1% decline year-over-year.
  • Rocket Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$246 M, a 10.7% decline from 2022.
  • Rocket Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$222 M, a 31.2% decline from 2021.
  • Rocket Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$169 M, a 21% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$249 M -$62.1 M -$3.72 M -6.38% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 -$246 M -$59.7 M +$7.06 M +10.6% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-27
Q3 2023 -$253 M -$61.9 M -$4.14 M -7.17% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-07
Q2 2023 -$249 M -$65.7 M -$11.3 M -20.8% Apr 1, 2023 Jun 30, 2023 10-Q 2023-11-07
Q1 2023 -$237 M -$58.3 M -$15.4 M -35.7% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 -$222 M -$66.7 M -$22.5 M -50.8% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-27
Q3 2022 -$199 M -$57.8 M -$7.64 M -15.2% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 -$192 M -$54.4 M -$19.9 M -57.6% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-07
Q1 2022 -$172 M -$43 M -$2.8 M -6.98% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-07
Q4 2021 -$169 M -$44.2 M +$16.7 M +27.4% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-27
Q3 2021 -$186 M -$50.1 M -$21 M -72.3% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-04
Q2 2021 -$165 M -$34.5 M -$9.49 M -37.9% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-04
Q1 2021 -$155 M -$40.2 M -$15.5 M -62.9% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-04
Q4 2020 -$140 M -$60.9 M -$41.1 M -207% Oct 1, 2020 Dec 31, 2020 10-K 2021-03-01
Q3 2020 -$98.6 M -$29.1 M -$9.8 M -50.8% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-05
Q2 2020 -$88.8 M -$25 M -$6.36 M -34% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-05
Q1 2020 -$82.5 M -$24.7 M -$5.21 M -26.8% Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-05
Q4 2019 -$77.3 M -$19.9 M +$7.46 M +27.3% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-01
Q3 2019 -$84.7 M -$19.3 M -$3.2 M -19.9% Jul 1, 2019 Sep 30, 2019 10-K 2021-03-01
Q2 2019 -$81.5 M -$18.7 M -$2.91 M -18.5% Apr 1, 2019 Jun 30, 2019 10-K 2021-03-01
Q1 2019 -$78.6 M -$19.5 M -$4.11 M -26.8% Jan 1, 2019 Mar 31, 2019 10-K 2021-03-01
Q4 2018 -$74.5 M -$27.3 M -$20.7 M -311% Oct 1, 2018 Dec 31, 2018 10-K 2019-03-08
Q3 2018 -$53.9 M -$16.1 M -$9.37 M -139% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-08
Q2 2018 -$44.5 M -$15.8 M -$12.2 M -348% Apr 1, 2018 Jun 30, 2018 10-Q 2019-11-08
Q1 2018 -$32.2 M -$15.3 M -$12.7 M -473% Jan 1, 2018 Mar 31, 2018 10-Q 2019-11-08
Q4 2017 -$19.6 M -$6.66 M -$29 M -130% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-08
Q3 2017 $9.38 M -$6.72 M +$4.41 M +39.6% Jul 1, 2017 Sep 30, 2017 10-K 2019-03-08
Q2 2017 $4.98 M -$3.52 M +$5.16 M +59.5% Apr 1, 2017 Jun 30, 2017 10-K 2019-03-08
Q1 2017 -$184 K -$2.68 M +$7.39 M +73.4% Jan 1, 2017 Mar 31, 2017 10-K 2019-03-08
Q4 2016 -$7.57 M $22.3 M +$30.5 M Oct 1, 2016 Dec 31, 2016 10-K 2019-03-08
Q3 2016 -$38.1 M -$11.1 M +$44.8 M +80.1% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-08
Q2 2016 -$82.9 M -$8.68 M -$6.3 M -264% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-03
Q1 2016 -$76.6 M -$10.1 M -$8.61 M -589% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q4 2015 -$68 M -$8.17 M -$6.02 M -280% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-16
Q3 2015 -$62 M -$56 M -$53.6 M -2243% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 -$8.39 M -$2.39 M +$460 K +16.2% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-10
Q1 2015 -$8.85 M -$1.46 M +$686 K +31.9% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-11
Q4 2014 -$9.53 M -$2.15 M Oct 1, 2014 Dec 31, 2014 10-K 2016-03-23
Q3 2014 -$2.39 M Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-12
Q2 2014 -$2.85 M Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-07
Q1 2014 -$2.15 M Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.